Great to see patient-reported outcomes (#PROs) 🔦at #ASCO24 across symptom science/ pall care + quality of care/ HSR tracks, incl as part of stepped models of care and in large real-world studies 👏👏. Here are my #ASCO24 PRO highlights:

Fox Chase Cancer Center presentations happening today, June 4, at the 2024 American Society of Clinical Oncology Annual Meeting (ASCO). #ASCO Efrat Dotan MD

My heart is full! It was such a pleasure to meet wonderful trailblazers from around the world and be a part of this tribe Women For Oncology at #ASCO24 #W4O for the win!!

🤩Efrat Dotan MD presents NCI CTEP Clinical Research @EAOnc EA2186: Randomized Phase II Gem/Nab-Paclitaxel vs. 5-FU/LV/ Liposomal Irinotecan in Older Pts with Tx-Naive Met Pancreatic Cancer (GIANT) #asco24 ASCO #cancer #cancerresearch noted NS difference in OS but demonstrates the imp of

It’s gonna be a good year!! #ASCO_LDP

About our guest: Dr. Chris Cann, MD is an Asst. Prof. of Hematology/Oncology at Fox Chase Cancer Center specializing in GI Onc. He received his MD from Lewis Katz School of Medicine. He completed IM residency and heme/onc fellowship at Vanderbilt Health. Dr. Cann has presented nationally on #EarlyOnsetCRC

#Adagrasib (+ cetux) now approved for metastatic colorectal cancer #crcsm w/ KRAS G12C after 5FU, Oxali, and Irinotecan based off #Krystal1: - 600mg BID dosing - ORR 34% & mDOR 5.8 mos - AEs ≥20% rash, GI, fatigue, pain, & hepatotoxicity #gism #OncTwitter #MedTwitter

Kudos to Chris Cann, MD for being his stellar self and making all of us proud. Thank you Dr. Cathy Eng for your mentorship and for the connection Fox Chase Cancer Center

Grateful to Fox Chase Cancer Center Social Work team for choosing topics and speakers for #NeuroendocrineTumor Support group Virtual so please join if you or your family member is affected by NETs and need help navigating their diagnosis

Adding the link foxchase.org/events/neuroen…

Amazing people make Fox Chase Cancer Center a special place. Our #NET program coordinator flaunting her #zebra look while spreading the word about the upcoming NET support group meeting !! You run our world Karen LACNETS NET Research Foundation NCAN CarcinoidCancer CCF

Biomarker testing for all patients with #CRC is a dream that needs to turn into reality Fight Colorectal Cancer Get Your Rear in Gear Philadelphia Colon Cancer Coalition

Updates on Pancreatic Neuroendocrine Neoplasms - 9th July. For more info, please see our website ukinets.org/2024/06/update…

Much awaited study and It did not disappoint! Kudos to Kristen Ciombor ECOG-ACRIN Cancer Research Group

35% pCR rate and 71% with major PR (>50%) using neoadjuvant novel dual ICI in MSS rectal cancer. Congratulations Pashtoon Kasi MD, MS ESMO - Eur. Oncology

MRD testing using a ctDNA to Predict Recurrence of Metastatic CRC Following Curative Intent Treatment doi.org/10.1158/1078-0… Clinical Cancer Research 👉52 pts, 230 samples, 69.2% of pts with recurrence👉Only ctDNA demonstrate statistical association with recurrence 🧐more data to support MRD

Day 1 of #ASCO_LDP , already so inspiring _ primer to all things that make ASCO great! I signed up for the #ACT Network to “Drive Knowledge to Action” as taught by Robin Zon, MD, FACP, FASCO Signup at asco.quorum.us/action_center/ and do your part #Advocacy Fox Chase Cancer Center

Lovely evening for a meal with some phenomenal oncologists after Day 2 of ASCO LDP. Thank you to Drs Merry-Jennifer Markham, MD, FACP, FASCO and Sumanta K. Pal, MD, FASCO for serving as mentors! 🙏🙌🤩

Chemo resistance plagues poorly differentiated #NECs. Guided by Whetstine Lab and collaboration with Heloisa Soares MD and Renuka Iyer, clinicaltrials.gov/study/NCT05420… is trying epigenetic modification with #Iadademstat to improve chemo benefit Fox Chase Cancer Center

#ASCO_LDP is not all work. There was a lot of play too with marshmallow and spaghetti skyscrapers, metro tour of DC and Alexandria with an amazing team Erin Cobain Stephen Chun Gita Thanarajasingam and our star mentor Sumanta K. Pal, MD, FASCO ASCO Fox Chase Cancer Center